{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T13:03:44Z","timestamp":1761311024426,"version":"build-2065373602"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,3,30]],"date-time":"2015-03-30T00:00:00Z","timestamp":1427673600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Universit\u00e0 Federico II","award":["GGP12108"],"award-info":[{"award-number":["GGP12108"]}]},{"name":"Programma Breve Mobilit\u00e0"},{"name":"Programma F.A.R.O. IV Tornata"},{"name":"Initiative d'Excellence","award":["ANR-11-LABX-0011-01"],"award-info":[{"award-number":["ANR-11-LABX-0011-01"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimie"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.biochi.2015.03.018","type":"journal-article","created":{"date-parts":[[2015,4,5]],"date-time":"2015-04-05T15:23:33Z","timestamp":1428247413000},"page":"54-58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Taming molecular flexibility to tackle rare diseases"],"prefix":"10.1016","volume":"113","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6147-6553","authenticated-orcid":false,"given":"Maria Vittoria","family":"Cubellis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6472-0486","authenticated-orcid":false,"given":"Marc","family":"Baaden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppina","family":"Andreotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biochi.2015.03.018_bib1","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jmb.2005.08.020","article-title":"Loss of protein structure stability as a major causative factor in monogenic disease","volume":"353","author":"Yue","year":"2005","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.biochi.2015.03.018_bib2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4155\/ppa.12.74","article-title":"Pharmacological chaperones for enzyme enhancement therapy in genetic diseases","volume":"2","author":"Aymami","year":"2013","journal-title":"Pharm. Pat. Anal."},{"key":"10.1016\/j.biochi.2015.03.018_bib3","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.cbpa.2013.04.009","article-title":"Targeting unfolded protein response signaling pathways to ameliorate protein misfolding diseases","volume":"17","author":"Ryno","year":"2013","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.biochi.2015.03.018_bib4","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1750-1172-5-30","article-title":"Fabry disease","volume":"5","author":"Germain","year":"2010","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.biochi.2015.03.018_bib5","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/4801","article-title":"Accelerated transport and maturation of lysosomal alpha-galactosidase A in Fabry lymphoblasts by an enzyme inhibitor","volume":"5","author":"Fan","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.biochi.2015.03.018_bib6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1056\/NEJM200107053450104","article-title":"Improvement in cardiac function in the cardiac variant of Fabry's disease with galactose-infusion therapy","volume":"345","author":"Frustaci","year":"2001","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.biochi.2015.03.018_bib7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/1750-1172-8-111","article-title":"Fabry_CEP: a tool to identify Fabry mutations responsive to pharmacological chaperones","volume":"8","author":"Cammisa","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.biochi.2015.03.018_bib8","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.chembiol.2011.10.012","article-title":"The molecular basis of pharmacological chaperoning in human alpha-galactosidase","volume":"18","author":"Guce","year":"2011","journal-title":"Chem. Biol."},{"key":"10.1016\/j.biochi.2015.03.018_bib9","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.bbagen.2013.12.018","article-title":"A\u00a0thermodynamic assay to test pharmacological chaperones for Fabry disease","volume":"1840","author":"Andreotti","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"year":"2011","series-title":"HGMD","author":"HGMD","key":"10.1016\/j.biochi.2015.03.018_bib10"},{"key":"10.1016\/j.biochi.2015.03.018_bib11","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F","article-title":"How well does a restrained electrostatic potential (RESP) model perform in calculating conformational energies of organic and biological molecules?","volume":"21","author":"Wang","year":"2000","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.biochi.2015.03.018_bib12","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/prot.20251","article-title":"Making optimal use of empirical energy functions: force-field parameterization in crystal space","volume":"57","author":"Krieger","year":"2004","journal-title":"Proteins"},{"key":"10.1016\/j.biochi.2015.03.018_bib13","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/prot.10104","article-title":"Increasing the precision of comparative models with YASARA NOVA\u2013a self-parameterizing force field","volume":"47","author":"Krieger","year":"2002","journal-title":"Proteins"},{"key":"10.1016\/j.biochi.2015.03.018_bib14","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/jcc.20291","article-title":"GROMACS: fast, flexible, and free","volume":"26","author":"Van Der Spoel","year":"2005","journal-title":"J.\u00a0Comput Chem."},{"issue":"Suppl 4","key":"10.1016\/j.biochi.2015.03.018_bib15","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1186\/1471-2105-6-S4-S8","article-title":"Secondary structure assignment that accurately reflects physical and evolutionary characteristics","volume":"6","author":"Cubellis","year":"2005","journal-title":"BMC Bioinforma."},{"issue":"Suppl 7","key":"10.1016\/j.biochi.2015.03.018_bib16","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1186\/1471-2105-14-S7-S9","article-title":"Identification and analysis of conserved pockets on protein surfaces","volume":"14","author":"Cammisa","year":"2013","journal-title":"BMC Bioinforma."},{"key":"10.1016\/j.biochi.2015.03.018_bib17","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2013a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J.\u00a0Comput Chem."},{"key":"10.1016\/j.biochi.2015.03.018_bib18","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/jhg.2010.5","article-title":"Prediction of the clinical phenotype of Fabry disease based on protein sequential and structural information","volume":"55","author":"Saito","year":"2010","journal-title":"J.\u00a0Hum. Genet."},{"issue":"3","key":"10.1016\/j.biochi.2015.03.018_bib19","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/cge.12261","article-title":"Intrafamilial phenotypic variability in four families with Anderson-Fabry disease","volume":"86","author":"Rigoldi","year":"2014","journal-title":"Clin. Genet."},{"key":"10.1016\/j.biochi.2015.03.018_bib20","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/00005792-200203000-00003","article-title":"Natural history of Fabry renal disease: influence of alpha-galactosidase A activity and genetic mutations on clinical course","volume":"81","author":"Branton","year":"2002","journal-title":"Med. Baltim."},{"year":"2006","series-title":"Genotype-phenotype Correlation in Fabry Disease","author":"Ries","key":"10.1016\/j.biochi.2015.03.018_bib21"},{"key":"10.1016\/j.biochi.2015.03.018_bib22","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1750-1172-6-66","article-title":"Therapy of Fabry disease with pharmacological chaperones: from in silico predictions to in\u00a0vitro tests","volume":"6","author":"Andreotti","year":"2011","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.biochi.2015.03.018_bib23","doi-asserted-by":"crossref","first-page":"e1003632","DOI":"10.1371\/journal.pgen.1003632","article-title":"Functional characterisation of alpha-galactosidase a mutations as a basis for a new classification system in fabry disease","volume":"9","author":"Lukas","year":"2013","journal-title":"PLoS Genet."},{"key":"10.1016\/j.biochi.2015.03.018_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3858\/emm.2009.41.1.001","article-title":"Effects of a chemical chaperone on genetic mutations in alpha-galactosidase A in Korean patients with Fabry disease","volume":"41","author":"Park","year":"2009","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.biochi.2015.03.018_bib25","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/humu.9520","article-title":"Novel mutations of the GLA gene in Japanese patients with Fabry disease and their functional characterization by active site specific chaperone","volume":"29","author":"Shimotori","year":"2008","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.biochi.2015.03.018_bib26","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/FPC.0b013e32830500f4","article-title":"Prediction of response of mutated alpha-galactosidase A to a pharmacological chaperone","volume":"18","author":"Shin","year":"2008","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.biochi.2015.03.018_bib27","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1086\/504601","article-title":"High incidence of later-onset fabry disease revealed by newborn screening","volume":"79","author":"Spada","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.biochi.2015.03.018_bib28","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/humu.21530","article-title":"A\u00a0pharmacogenetic approach to identify mutant forms of alpha-galactosidase A that respond to a pharmacological chaperone for Fabry disease","volume":"32","author":"Wu","year":"2011","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.biochi.2015.03.018_bib29","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1042\/BJ20070479","article-title":"Mutant alpha-galactosidase A enzymes identified in Fabry disease patients with residual enzyme activity: biochemical characterization and restoration of normal intracellular processing by 1-deoxygalactonojirimycin","volume":"406","author":"Ishii","year":"2007","journal-title":"Biochem. J."},{"key":"10.1016\/j.biochi.2015.03.018_bib30","doi-asserted-by":"crossref","first-page":"4816","DOI":"10.1021\/bi9002265","article-title":"Effects of pH and iminosugar pharmacological chaperones on lysosomal glycosidase structure and stability","volume":"48","author":"Lieberman","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.biochi.2015.03.018_bib31","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1750-1172-5-36","article-title":"Prediction of the responsiveness to pharmacological chaperones: lysosomal human alpha-galactosidase, a case of study","volume":"5","author":"Andreotti","year":"2010","journal-title":"Orphanet J. Rare Dis."}],"container-title":["Biochimie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908415000875?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908415000875?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T01:07:56Z","timestamp":1759540076000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300908415000875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":31,"alternative-id":["S0300908415000875"],"URL":"https:\/\/doi.org\/10.1016\/j.biochi.2015.03.018","relation":{},"ISSN":["0300-9084"],"issn-type":[{"type":"print","value":"0300-9084"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Taming molecular flexibility to tackle rare diseases","name":"articletitle","label":"Article Title"},{"value":"Biochimie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biochi.2015.03.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}